Cyclosporin A

Cyclosporin A Struktur
59865-13-3
CAS-Nr.
59865-13-3
Englisch Name:
Cyclosporin A
Synonyma:
CYCLOSPORINE;CICLOSPORIN;CYCLOSPORINE A;Restasis;sandimmune;Neoral;CICLOSPORIN A;CL285;Cipol N;s7481f1
CBNumber:
CB5163816
Summenformel:
C62H111N11O12
Molgewicht:
1202.61
MOL-Datei:
59865-13-3.mol

Cyclosporin A Eigenschaften

Schmelzpunkt:
148-151°C
Siedepunkt:
838.63°C (rough estimate)
alpha 
D20 -244° (c = 0.6 in chloroform); D20 -189° (c = 0.5 in methanol)
Dichte
0.9913 (rough estimate)
Brechungsindex
1.6500 (estimate)
Flammpunkt:
87℃
storage temp. 
-20°C
Löslichkeit
ethanol: 30 mg/mL
Aggregatzustand
solid
pka
13.32±0.70(Predicted)
Farbe
white
Wasserlöslichkeit
Soluble in dimethyl sulfoxide and ethanol. Insoluble in water.
Merck 
14,2752
BRN 
3647785
Stabilität:
Stable for 3 years as supplied. Solutions in DMSO or ethanol may be stored at -20°C for up to 3 months.
InChIKey
PMATZTZNYRCHOR-CGLBZJNRSA-N
CAS Datenbank
59865-13-3(CAS DataBase Reference)
IARC
1 (Vol. 50, 100A) 2012
EPA chemische Informationen
Cyclosporin A (59865-13-3)
Sicherheit
  • Risiko- und Sicherheitserklärung
  • Gefahreninformationscode (GHS)
Kennzeichnung gefährlicher T,Xn,F
R-Sätze: 45-60-22-40-36-20/21/22-11
S-Sätze: 53-45-36/37-24/25-22-26-16
RIDADR  UN 1648 3 / PGII
WGK Germany  3
RTECS-Nr. GZ4120000
HS Code  29419090
Giftige Stoffe Daten 59865-13-3(Hazardous Substances Data)
Toxizität LD50 in mice, rats, rabbits (mg/kg): 107, 25, >10 i.v.; 2329, 1480, >1000 orally (Ryffel)
Bildanzeige (GHS) GHS hazard pictogramsGHS hazard pictograms
Alarmwort Achtung
Gefahrenhinweise
Code Gefahrenhinweise Gefahrenklasse Abteilung Alarmwort Symbol P-Code
H302 Gesundheitsschädlich bei Verschlucken. Akute Toxizität oral Kategorie 4 Warnung GHS hazard pictogramssrc="/GHS07.jpg" width="20" height="20" /> P264, P270, P301+P312, P330, P501
H350 Kann Krebs verursachen. Karzinogenität Kategorie 1A Achtung GHS hazard pictogramssrc="/GHS08.jpg" width="20" height="20" />
Sicherheit
P201 Vor Gebrauch besondere Anweisungen einholen.
P202 Vor Gebrauch alle Sicherheitshinweise lesen und verstehen.
P264 Nach Gebrauch gründlich waschen.
P264 Nach Gebrauch gründlich waschen.
P270 Bei Gebrauch nicht essen, trinken oder rauchen.
P301+P312 BEI VERSCHLUCKEN: Bei Unwohlsein GIFTINFORMATIONSZENTRUM/Arzt/... (geeignete Stelle für medizinische Notfallversorgung vom Hersteller/Lieferanten anzugeben) anrufen.
P308+P313 BEI Exposition oder falls betroffen: Ärztlichen Rat einholen/ärztliche Hilfe hinzuziehen.

Cyclosporin A Chemische Eigenschaften,Einsatz,Produktion Methoden

R-Sätze Betriebsanweisung:

R45:Kann Krebs erzeugen.
R60:Kann die Fortpflanzungsfähigkeit beeinträchtigen.
R22:Gesundheitsschädlich beim Verschlucken.
R40:Verdacht auf krebserzeugende Wirkung.

S-Sätze Betriebsanweisung:

S53:Exposition vermeiden - vor Gebrauch besondere Anweisungen einholen.
S45:Bei Unfall oder Unwohlsein sofort Arzt zuziehen (wenn möglich, dieses Etikett vorzeigen).
S36/37:Bei der Arbeit geeignete Schutzhandschuhe und Schutzkleidung tragen.
S24/25:Berührung mit den Augen und der Haut vermeiden.
S22:Staub nicht einatmen.

Beschreibung

Cyclosporine A is a powerful immunosuppressive drug intended for preventing rejection of kidney, heart, and lung transplants. A new era in the development of immunopharmacology began with the discovery of cyclosporines. Cyclosporines are produced by mycelial mushrooms Tolypocladium inflatum, Tricoderma polysporum, and Cylindrocarpon lucidum, which are found in the ground.
Cyclosporine A is the first drug to affect a specific line of protecting cells of the body. Unlike usual cytotoxics, it suppresses T-cells and acts on all cell lines simultaneously. Cyclosporine A significantly eases the ‘reception’ of transplants, and increases the possibility of treating autoimmune system diseases.

Chemische Eigenschaften

White or almost white powder

Verwenden

Cyclosporin A is a hydrophobic cyclic peptide isolated from several fungal species including Cylindrocarpon, Fusarium, Trichoderma and Tolypocladium. Cyclosporin A inhibits T-cell activation and has been marketed since 1983 as an immunosuppressant in post-allogeneic organ transplant. Cyclosporin A acts by binding to the protein, cyclophilin (immunophilin), in T-lymphocytes causing inhibition of calcineurin (protein phosphatase 2B). Cyclosporin A reduces transcription of interleukin 2, and inhibits lymphokine production, interleukin release and NO synthesis induced by interleukin 1α, lipopolysaccharides and TNFα.

Definition

ChEBI: A cyclic nonribosomal peptide of eleven amino acids; an immunosuppressant drug widely used in post-allogeneic organ transplant to reduce the activity of the patient's immune system, and therefore the risk of organ rejection. Also causes reversible inhibiti n of immunocompetent lymphocytes in the G0- and G1-phase of the cell cycle.

Indications

Allgemeine Beschreibung

White prismatic needles (from acetone) or white powder.

Air & Water Reaktionen

Slightly water soluble .

Reaktivität anzeigen

Cyclosporin A is an amide. Amides/imides react with azo and diazo compounds to generate toxic gases. Flammable gases are formed by the reaction of organic amides/imides with strong reducing agents. Amides are very weak bases (weaker than water). Imides are less basic yet and in fact react with strong bases to form salts. That is, they can react as acids. Mixing amides with dehydrating agents such as P2O5 or SOCl2 generates the corresponding nitrile. The combustion of these compounds generates mixed oxides of nitrogen (NOx).

Health Hazard

SYMPTOMS: Symptoms of exposure to Cyclosporin A include hepatotoxicity, nephrotoxicity, hyperkalemia, hyperuricemia, convulsions, renal dysfunction, tremor, hirsutism, hypertension, gum hyperplasia, cramps, acne, headache, diarrhea, nausea, vomiting, abdominal discomfort, paresthesia, flushing, leukopenia, lymphoma, sinusitis and gynecomastia. In 2% or less of persons exposed, it has caused allergic reactions, anemia, anorexia, confusion, conjunctivitis, edema, fever, brittle fingernails, gastritis, hearing loss, hiccups, hyperglycemia, muscle pain, peptic ulcer, thrombocytopenia and tinnitus. Rare reactions include anxiety, chest pain, constipation, depression, hair breaking hematuria, joint pain, lethargy, mouth sores, myocardial infarction, night sweats, pancreatitis, pruritus, swallowing difficulty, tingling, upper gastrointestinal bleeding, visual disturbance, weakness and weight loss. It has caused kidney and liver damage. An increased susceptibility to infection may occur. Other symptoms include gastrointestinal disturbance, rashes and angioedema.

Brandgefahr

Flash point data for Cyclosporin A are not available; however, Cyclosporin A is probably combustible.

Pharmakologie

Cyclosporine has no direct effect on keratinocytes and is not a mitotic inhibitor. Cyclosporine inhibits cytokine release, which results in a decreased recruitment of APCs into the epidermis and decreases immunoreactivity of lesions. Potential long-term side effects preclude cyclosporine’s use in all but very severe and recalcitrant psoriasis. Cyclosporine can be combined with lowdose methotrexate.

Nebenwirkungen

Cyclosporine’s main side effects, even at low doses, are hypertension and nephrotoxicity. Age, baseline blood pressure, and baseline creatinine levels are predictors of higher risks of side effects. Glomerular filtration rate (GFR) is a more sensitive test than creatinine for evaluating renal function, and a baseline is recommended in any high-risk patient. Longterm treatment with CSA may induce interstitial fibrosis and glomerular sclerosis, with more pronounced changes directly associated with duration of therapy. It should be administered only by dermatologists experienced in its use.

Sicherheitsprofil

Confirmed carcinogen producing Hodghn's dlsease. Experimental reproductive effects. Poison by intraperitoneal and intravenous routes. Moderately toxic by ingestion. Human systemic effects by ingestion: increased body temperature, cyanosis. Mutation data reported. When heated to decomposition it emits toxic fumes of NOx.

mögliche Exposition

Cyclosporin A is a fungal metabolite; an amide immunosuppressant drug used in various surgeries.

Carcinogenicity

Cyclosporin A is known to be a human carcinogen based on sufficient evidence of carcinogenicity from studies in humans.

Versand/Shipping

UN3249 Medicine, solid, toxic, n.o.s., Hazard Class: 6.1; Labels: 6.1-Poisonous materials.

Inkompatibilitäten

Amides/imides react with azo and diazo compounds to generate toxic gases. Flammable gases are formed by the reaction of organic amides/imides with strong reducing agents such as hydrideds and active metals. Amides are very weak bases (weaker than water). Imides are less basic yet and in fact react with strong bases to form salts. That is, they can react as acids. Mixing amides with dehydrating agents such as such as phosphorus pent- oxide or thionyl chloride generates the corresponding nitrile. The combustion of these compounds generates mixed oxides of nitrogen (NOx).

Waste disposal

t is inappropriate and possibly dangerous to the environment to dispose of expired or waste drugs and pharmaceuticals by flushing them down the toilet or discarding them to the trash. Household quantities of expired or waste pharmaceuticals may be mixed with wet cat litter or coffee grounds, double-bagged in plastic, discard in trash. Larger quantities shall carefully take into consider- ation applicable DEA, EPA, and FDA regulations. If possi- ble return the pharmaceutical to the manufacturer for proper disposal being careful to properly label and securely package the material. Alternatively, the waste pharmaceutical shall be labeled, securely packaged, and transported by a state licensed medical waste contractor to dispose by burial in a licensed hazardous or toxic waste landfill or incinerator.

Cyclosporin A Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


Cyclosporin A Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 650)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Henan Tengmao Chemical Technology Co. LTD
+8615238638457
salesvip2@hntmhg.com China 415 58
Henan Bao Enluo International TradeCo.,LTD
+86-17331933971 +86-17331933971
deasea125996@gmail.com China 2503 58
Shaanxi Haibo Biotechnology Co., Ltd
+undefined18602966907
qinhe02@xaltbio.com China 1000 58
Shanghai Affida new material science and technology center
+undefined15081010295
2691956269@qq.com China 359 58
Hebei Kangcang new material Technology Co., LTD
+8619133911216
fanfan@kangcang.com.cn China 340 58
Shaanxi TNJONE Pharmaceutical Co., Ltd
+8618740459177
sarah@tnjone.com China 893 58
Capot Chemical Co.,Ltd.
571-85586718 +8613336195806
sales@capotchem.com China 29797 60
Henan Tianfu Chemical Co.,Ltd.
+86-0371-55170693 +86-19937530512
info@tianfuchem.com China 21691 55
ATK CHEMICAL COMPANY LIMITED
+undefined-21-51877795
ivan@atkchemical.com China 32480 60
Shanghai Zheyan Biotech Co., Ltd.
18017610038
zheyansh@163.com CHINA 3620 58

59865-13-3()Verwandte Suche:


  • ol27-400
  • s7481f1
  • sandimmun
  • Cyclospori
  • 1,4,7,10,13,16,19,22,25,28,31-Undecaazacyclotritriacontane, cyclic peptide deriv.
  • 30-Ethyl-33-(1-hydroxy-2-methyl-hex-4-enyl)-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-dipropan-2-yl-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
  • Cipol N
  • Neoplanta
  • (3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-Ethyl-33-[(E,1R,2R)-1-hydroxy-2-methyl-hex-4-enyl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-dipropan-2-yl-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,
  • (3R,4R)-3-Hydroxy-N-methyl-5-[(E)-1-propenyl]-cyclo(L-Leu-L-Abu-Sar-N-methyl-L-Leu-L-Val-N-methyl-L-Leu-L-Ala-D-Ala-N-methyl-L-Leu-N-methyl-L-Leu-N-methyl-L-Val-)
  • Cicloporin A
  • Cyclosporin A,Antibiotic S 7481F1, Cyclosporine
  • CYCLOSPORIN A (ANTIBIOTIC S 7481FI)
  • Cyclosporine (50 mg)
  • Cyclosporin A(Antibiotic S 7481F1)
  • Ciclosporin API
  • Cyclosporine IMpurity-A
  • A,Cyclosporin
  • Cyclosporine-d4/ Cyclosporin A-d4
  • oil solution
  • CiclosporinOralSolution
  • ANTIBIOTIC S 7481F1
  • ANTIBIOTIC S 7481FI
  • CYCLOSPORIN A
  • CYCLOSPORIN A, FUSARIUM SOLANI
  • CYCLOSPORIN A, TOLYPOCLADIUM INFLATUM
  • RAMIHYPHIN A
  • Cyclosporin A USP26/EPIV
  • CYCLOSPORIN A, MOLECULAR BIOLOGYREAGENT
  • CyclosporinAfromFusariumsolani
  • CYCLOSPORINA(PATENTED-NOSUPPLY)
  • Cyclosporin A / B / C / D / H
  • CYCLOSPORIN USP
  • Cyclosporine, Trichoderma polysporum
  • Cyclosprin
  • Lo-27400
  • Sandimmum(e)
  • CYCLOSPORINE USP
  • Antibiotic S 7481F1, Cyclosporine
  • Cyclosporin A from Tolypocladium inflatum
  • Atopica
  • Optimmune
  • Ciclosporin, RaMihyphin A, OL 27-400, CyA, S 7481F1
  • Cyclosporin A (Cyclosporine A)
  • Cyclosporin A solution
  • Cyclosporin A, >=98%
  • MEDIABAG SACHETS FOR 450 ML BPW
  • osporin A
  • Cyclosporin A Crude
  • Cyclosporin A, Tolypocladium inflatum - CAS 59865-13-3 - Calbiochem
  • CL285
  • NSC 290193
  • Cyclosporin A, 99%, an immunosuppressive agent
  • CsA, Cyclosporin A
  • Cyclosporin A >
  • Ciclosporin RS
  • Ciclosporin CRS
  • Ciclosporin for system suitability CRS
Copyright 2019 © ChemicalBook. All rights reserved